Published in Am J Hosp Pharm on July 15, 1994
Physicochemical stability of ternary admixtures of butorphanol, ketamine, and droperidol in polyolefin bags for patient-controlled analgesia use. Drug Des Devel Ther (2016) 0.75
Incompatibilities of lornoxicam with 4 antiemetic medications in polyolefin bags during simulated intravenous administration. Medicine (Baltimore) (2016) 0.75
Physical compatibility of melphalan with selected drugs during simulated Y-site administration. Am J Hosp Pharm (1993) 1.37
Compatibility of piperacillin sodium plus tazobactam with selected drugs during simulated Y-site injection. Am J Hosp Pharm (1994) 1.03
Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration. Am J Health Syst Pharm (1997) 0.92
Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration. Am J Health Syst Pharm (1997) 0.90
Compatibility of parenteral nutrient solutions with selected drugs during simulated Y-site administration. Am J Health Syst Pharm (1997) 0.86
Compatibility of medications with 3-in-1 parenteral nutrition admixtures. JPEN J Parenter Enteral Nutr (1999) 0.85
Chromosomal diversity in Hypostomus (Siluriformes, Loricariidae) with emphasis on physical mapping of 18S and 5S rDNA sites. Genet Mol Res (2013) 0.81
Ondansetron compatible with sodium acetate. J Clin Oncol (1993) 0.80
Stability of paclitaxel in 5% dextrose injection or 0.9% sodium chloride injection at 4, 22, or 32 degrees C. Am J Hosp Pharm (1994) 0.77
Compatibility of amifostine with selected drugs during simulated Y-site administration. Am J Health Syst Pharm (1995) 0.75
Turbidimetric assessment of the compatibility of taxol with 42 other drugs during simulated Y-site injection. Am J Hosp Pharm (1993) 0.75
Compatibility of filgrastim with selected drugs during simulated Y-site administration. Am J Hosp Pharm (1994) 0.75
Compatibility and stability of ondansetron hydrochloride with morphine sulfate and with hydromorphone hydrochloride in 0.9% sodium chloride injection at 4, 22, and 32 degrees C. Am J Hosp Pharm (1994) 0.75
Compatibility of etoposide phosphate with selected drugs during simulated Y-site injection. J Am Pharm Assoc (Wash) (1999) 0.75
Stability of thiotepa (lyophilized) in 5% dextrose injection at 4 and 23 degrees C. Am J Health Syst Pharm (1996) 0.75
Compatibility of paclitaxel injection vehicle with intravenous administration and extension sets. Am J Hosp Pharm (1994) 0.75
Compounding an extended-stability admixture of Paclitaxel for long-term infusion. Int J Pharm Compd (2013) 0.75
Compatibility of doxorubicin hydrochloride liposome injection with selected other drugs during simulated Y-site administration. Am J Health Syst Pharm (1997) 0.75
Rapid loss of fentanyl citrate admixed with fluorouracil in polyvinyl chloride containers. Ann Pharmacother (1997) 0.75
Stability of metoclopramide hydrochloride in plastic syringes. Am J Health Syst Pharm (1996) 0.75
Compatibility of aztreonam with selected drugs during simulated Y-site administration. Am J Health Syst Pharm (1995) 0.75
Compatibility of ciprofloxacin lactate with sodium bicarbonate during simulated Y-site administration. Am J Health Syst Pharm (1997) 0.75
Stability of cisatracurium besylate in vials, syringes, and infusion admixtures. Am J Health Syst Pharm (1998) 0.75
Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration. Am J Health Syst Pharm (1997) 0.75
Suloctidil: long-term trial in the aged. Study of microcirculation, viscosity, red cell deformability, fibrinolysis and lipid fractions. Arzneimittelforschung (1985) 0.75
Compatibility of gemcitabine hydrochloride with 107 selected drugs during simulated Y-site injection. J Am Pharm Assoc (Wash) (1999) 0.75
Compatibility of granisetron hydrochloride with selected alkaline drugs. Am J Health Syst Pharm (1995) 0.75
Incompatibility of fluorouracil with leucovorin calcium or levoleucovorin calcium. Am J Health Syst Pharm (1995) 0.75
Compatibility of remifentanil hydrochloride with selected drugs during simulated Y-site administration. Am J Health Syst Pharm (1997) 0.75
Compatibility and stability of paclitaxel combined with cisplatin and with carboplatin in infusion solutions. Ann Pharmacother (1997) 0.75
Visual, turbidimetric, and particle-content assessment of compatibility of vinorelbine tartrate with selected drugs during simulated Y-site injection. Am J Hosp Pharm (1994) 0.75
Stability of acyclovir sodium 1, 7, and 10 mg/mL in 5% dextrose injection and 0.9% sodium chloride injection. Am J Health Syst Pharm (1998) 0.75
Compatibility and stability of aztreonam and vancomycin hydrochloride. Am J Health Syst Pharm (1995) 0.75
Idarubicin hydrochloride turbidity versus incompatibility. Am J Hosp Pharm (1993) 0.75
Compatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administration. Am J Health Syst Pharm (1996) 0.75
Stability and compatibility of fluorouracil with morphine sulfate and hydromorphone hydrochloride. Ann Pharmacother (1996) 0.75